Dr. Julien Oleg, Partner and Global Leader at IBM, joins us to describe updates in the pharma world and how the process works for the multiple myeloma treatment pipeline (from drug design all the way to commercialization).
As a consumer of these medications, it's important for you to know how they get to you. Understand the complicated world of the pharma industry and have a stronger understanding of the medicines that you are taking.
We look forward to a great discussion.
Audrey introduces the agenda of the event and our featured speaker Dr. Julien Oleg.
Dr. Julien Oleg describes updates in the pharma world and how the process works for the multiple myeloma treatment pipeline
Type your questions in the chat and we will answer them!
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Dr. Julien Oleg Kucheryavenko Willard is a Partner in the IBM’s Enterprise Strategy group and leads a global technology strategy practice for healthcare and life sciences as well as an IBM’s Cell & Gene and Precision Medicine group. Dr. Willard is a trained clinician, public health, and a data science for economics professional and spent his career at the intersection of global health, technology, and health equity working in the areas of maternal and child health, opioid use, HIV and hepatitis C treatment access.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113